rct
    2019
    High Quality

    Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial

    Unknown authors

    Published in Lancet

    Key Findings

    Ursodeoxycholic acid did not reduce the composite adverse perinatal outcome compared with placebo.

    Conclusions

    Well-designed null trial for the reference bile-flow agent.

    Outcomes Measured

    Bile Flow Enhancement
    Primary

    Ursodeoxycholic acid did not reduce the composite adverse perinatal outcome compared with placebo.

    Study Details

    Year:2019
    Quality Score:9/10

    Access Study

    View on DOIView on PubMedOriginal Source

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.